






403 - Forbidden: Access is denied.



Server Error


403 - Forbidden: Access is denied.
You do not have permission to view this directory or page using the credentials that you supplied.






SVEN  WEHRWEIN - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











SVEN  WEHRWEIN
Check out list of companies and businesses related to SVEN  WEHRWEIN. Find out SVEN  WEHRWEIN address and contact details. View other people related to SVEN  WEHRWEIN - coworkers, colleagues, companions, etc.
Address:   

4877 E. LAKE HARRIET PARKWAY  MINNEAPOLIS 55419 MN




Companies related to SVEN  WEHRWEIN
CIKCompany NamePositionCompany Address0000780127SYNOVIS LIFE TECHNOLOGIES INCDirector 2575 UNIVERSITY AVENUE  ST PAUL 55114-10240000890846UROPLASTY INCDirector 5420 FELTL ROAD  MINNETONKA 553430000894237COGENTIX MEDICAL INC /DE/Director 5420 FELTL ROAD  MINNETONKA 553430001092699SPS COMMERCE INCDirector 333 SOUTH SEVENTH STREET SUITE 1000 MINNEAPOLIS 554020001323885AtriCure, Inc.Director 7555 INNOVATION WAY  MASON 450400001443669Proto Labs IncDirector 5540 Pioneer Creek  Maple Plain 55359




SVEN  WEHRWEIN on the Web
Persons related to SVEN  WEHRWEIN - SYNOVIS LIFE TECHNOLOGIES INCNamePositionCityFARIBORZ BOOR  BOORPresident and COO ST. PAULDAVID A  BUCHEVP Marketing and Sales ST. PAULDAVID A  BUCHEVP Marketing & Sales DAVID A  BUCHEVP of SLT, Inc.; COO of SSI ST. PAULDAVID A  BUCHEST. PAULDAVID A  BUCHEVP of SLT, Inc., COO of SSI ST. PAULDAVID A  BUCHEVP of SLT, Inc; COO of SSI ST. PAULMICHAEL K  CAMPBELLPresident of MCA BIRMINGHAMMICHAEL K  CAMPBELLPresident of MCA ST. PAULMICHAEL K  CAMPBELLPresident of MCA ST.PAULMICHAEL K  CAMPBELLPresident of MCA ST. PAULTIMOTHY F  FLOEDERVP of Corporate Development ST. PAULTIMOTHY F  FLOEDERVP of Corporate Development ST. PAULMARY LOU  FRICKVP of Regulatory Affairs ST. PAULMARY LOU  FRICKVP of Regulatory Affairs ST. PAULMARY LOU  FRICKVP of Regulatory Affairs ST. PAULEVAN  JOHNSTONVice President of Operations ST. PAULWILLIAM G  KOBIDirector ST. PAULWILLIAM G  KOBIDirector MINNETONKARICHARD W  KRAMPMEDINARICHARD W  KRAMPPresident, COO of SIS MEDINARICHARD W  KRAMPPresident, COO of SIS LILYDALERICHARD W  KRAMPPresident of SLT ST. PAULRICHARD W  KRAMPPresident and CEO ST. PAULRICHARD P  LANIGANGM of OWC ST. PAULKAREN GILLES  LARSONPresident and CEO ST. PAULKAREN GILLES  LARSONDirector ST. PAULKAREN GILLES  LARSONPresident and CEO ST. PAULKAREN GILLES  LARSONDirector ST. PAULKAREN GILLES  LARSONDirector ST. PAULCONNIE L  MAGNUSONVP Finance and CFO ST. PAULDaniel L.  MooradianVP of R&D ST. PAULB NICHOLAS  ORAYB NICHOLAS  ORAYVP of Research & Development ST. PAULMark F  PalmaDirector CAMERONMark F  PalmaDirector ST. PAULMark F  PalmaDirector ST. PAULMark F  PalmaDirector ST. PAULRICHARD W  PERKINSDirector WAYZATARICHARD W  PERKINSDirector ST. PAULRICHARD W  PERKINSDirector ST. PAULRICHARD W  PERKINSDirector WAYZATARICHARD W  PERKINSDirector WAYZATARICHARD W  PERKINSDirector WAYZATAANTON R  POTAMIANTON R  POTAMIDirector ST PAULBrett  ReynoldsCFO/Vice President of Finance ST. PAULTIMOTHY M  SCANLANTIMOTHY M  SCANLANDirector ST. PAULTIMOTHY M  SCANLANDirector ST. PAULTIMOTHY M  SCANLANDirector ST. PAULTIMOTHY M  SCANLANDirector ST. PAULTIMOTHY M  SCANLANDirector ST. PAULJohn D  SeabergDirector ST PAULJohn D  SeabergDirector ST PAULEDWARD E  STRICKLANDDirector FRIDAY HARBORSVEN  WEHRWEINDirector MINNEAPOLISSVEN  WEHRWEINDirector ST. PAULSVEN  WEHRWEINDirector ST. PAULPersons related to SVEN  WEHRWEIN - UROPLASTY INCNamePositionCityCystoMedix, Inc.ANDOVERDarin  HammersSr VP Global Sales & Marketing MINNETONKADarin  HammersSr VP Global Sales & Marketing MINNETONKACHRISTOPHER  HARRISVice President THE NETHERLANDSHeartland Value Manager LLCMILWAUKEELARRY R  HEINEMANNV.P. Sales & Marketing LARRY R  HEINEMANNVice President HUDSONLARRY R  HEINEMANNVice President HUDSONLARRY R  HEINEMANNVP of Global Sales HUDSONLARRY R  HEINEMANNVP of Global Sales MINNETONKALARRY R  HEINEMANNVice President of Global Sales MINNETONKAMARC  HERREGRAVENVice President FALCON HEIGHTSMARC  HERREGRAVENVice President FALCOLN HEIGHTSMARC  HERREGRAVENVP Manufacturing FALCON HEIGHTSMARC  HERREGRAVENVP Manufacturing MINNETONKAMARC  HERREGRAVENVice President Manufacturing MINNETONKADANIEL G  HOLMANDirector MINNEAPOLISDANIEL G  HOLMANCFO MINNEAPOLISDANIEL G  HOLMAN EDEN PRAIRIESUSAN HARTJES  HOLMANCOO MINNEAPOLISSUSAN HARTJES  HOLMANCOO MINNEAPOLISSUSAN HARTJES  HOLMANCOO MINNEAPOLLISSUSAN HARTJES  HOLMANCOO EDEN PRAIRIESUSAN HARTJES  HOLMANCOO MINNETONKASUSAN HARTJES  HOLMANSr. VP Operations & Regulatory MINNETONKASAM B  HUMPHRIESSAM B  HUMPHRIESPresident BLOOMINGTONTHOMAS EDWARD  JAMISONTHOMAS EDWARD  JAMISONDirector MINNEAPOLISTHOMAS EDWARD  JAMISONDirector MINNEAPOLISTHOMAS EDWARD  JAMISONDirector MINNEAPOLISTHOMAS EDWARD  JAMISONDirector MINNEAPOLOSTHOMAS EDWARD  JAMISONDirector WOODBURYTHOMAS EDWARD  JAMISONDirector MINNETONKAMahedi A  JiwaniMINNEAPOLISMahedi A  JiwaniVP, CFO, Treasurer EDINAMahedi A  JiwaniVP, CFO, Treasurer MINNETONKAMahedi A  JiwaniVice President, CFO, Treasurer MINNETONKADAVID B  KAYSENPresident, CEO BLOOMINGTONDAVID B  KAYSENPresident, CEO MINNETONKADAVID B  KAYSENPresident, CEO MINNETONKADAVID B  KAYSENPresident, CEO MINNETONKARobert  KillPresident and CEO MINNETONKARobert  KillMINNETONKARobert  KillPresident, CEO MINNETONKARobert  KillPresident and CEO MINNETONKANancy A  KolbMINNETONKANancy A  KolbVicePresident Global Marketing MINNETONKAA J  KOOLEController ROERMONDA J  KOOLEController THE NETHERLANDSA J  KOOLEController A J  KOOLEController, Managing Director 6215 JP MAASTRICHTA Jones  LeeDirector FRIDLEYA Jones  LeeDirector FRIDLEYA Jones  LeeDirector MINNETONKAROBERT PATRICK  MAXWELLDirector MINNETONKAROBERT PATRICK  MAXWELLDirector MINNETONKAROBERT PATRICK  MAXWELLDirector MINNETONKAROBERT PATRICK  MAXWELLDirector MINNETONKABRUCE P  MINDICH10% Owner PARAMUSBRUCE P  MINDICH10% Owner TARRYTOWNMindich Family LTD Liability CO10% Owner PARAMUSWILLIAM J  NASGOVITZMILWAUKEEKenneth H  PaulusDirector MINNETONKAJOEL  PITLORDirector CAMBRIDGEJOEL  PITLORDirector WALTHAMBrett  ReynoldsSr. Vice President and CFO ST. PAULBrett  ReynoldsSenior V.P. CFO MINNETONKABrett  ReynoldsSenior Vice President and CFO MINNETONKAKEVIN H  ROCHEDirector MINNETONKAKEVIN H  ROCHEDirector MINNETONKAMICHAEL  ROTH10% Owner ST. FRANCISMICHAEL  ROTH10% Owner ST. FRANCISBRIAN JAY  STARKST. FRANCISBRIAN JAY  STARKST. FRANCISBRIAN JAY  STARKST FRANCISJames P  StaunerDirector LAKE FORESTJames P  StaunerDirector MINNETONKAJames P  StaunerDirector MINNETONKATAPESTRY INVESTMENT PARTNERS LP10% Owner TURN OF THE TIDE A WISCONSIN LPMILWAUKEESVEN  WEHRWEINDirector MINNEAPOLISSVEN  WEHRWEINDirector MINNETONKASVEN  WEHRWEINDirector MINNETONKAPersons related to SVEN  WEHRWEIN - COGENTIX MEDICAL INC /DE/NamePositionCityAccelmed Growth Partners (AGP) LtdHERZLIYA PITUACHAccelmed Growth Partners (GP), L.P.HERZLIYA PITUACHAccelmed Growth Partners, L.P.HERZLIYA PITUACHAccelmed Growth Partners Management Ltd.HERZLIYA PITUACHDavid W  AndersonDirector MONTGOMERYVILLEDavid W  AndersonDirector MONTGOMERYDavid W  AndersonDirector ORANGEBURGDavid W  AndersonDirector MONTGOMERYVILLECynthia F.  AnsariPresident and CEO ORANGEBURGKENNETH W  ANSTEYDirector NATICKKENNETH W  ANSTEYDirector ORANGEBURGKENNETH W  ANSTEYDirector ORANGEBURGKENNETH W  ANSTEYMINNEAPOLISCarlos  BabiniFREMONTCarlos  BabiniEASTONWarren L  BielkeDirector EDEN PRAIRIEWarren L  BielkeDirector ORANGEBURGWarren L  BielkeInterim CEO EDEN PRARIEPolsky  BruceOrangeburgYoav M  CohenChief Financial Officer ORANGEBURGJames A  D'OrtaDirector MINNETONKAKeith J. C.  DarraghVice President, Finance ORANGEBURGAnderson  DavidOrangeburgGerald D  ErbVP Marketing & Sales FISHERSUri  GeigerHERZELIARON  HADANIChief Executive Officer TEANECKRON  HADANIChief Executive Officer TEANECKRON  HADANIChief Executive Officer ORANGEBURGRON  HADANITEANECKDarin  HammersCEO MINNETONKADavid  HanukaORANGEBURGDavid  HanukaVP, Research and Development ORANGEBURGGideon  HirschmannORANGEBURGGideon  Hirschmann ORANGEBURGGideon  HirschmannVice President of Operations ORANGEBURGGideon  HirschmannORANGEBURGRydzewski  JohnOrangeburgWolf  KatherineOrangeburgOneda  KatsumiOrangeburgRobert  KillChairman, President and CEO MINNETONKALOTHAR  KOOBDirector PEABODYLOTHAR  KOOBORANGEBURGLOTHAR  KOOBDirector ORANGEBURGMARK S  LANDMANVP Operations, Medical Segment SHARONMARK S  LANDMANVP, Disposables Operations ORANGEBURGMARK S  LANDMANVice President Pell  LewisOrangeburgKoob  LotharOrangeburgTHOMAS M  OLMSTEADVP Sales Medical Segment UNIVERSITY HEIGHTSKATSUMI  ONEDAChairman of BOD ALPINEKATSUMI  ONEDADirector ORANGEBURGKATSUMI  ONEDADirector JITENDRA  PATELVP Sales Industrial Segment NORWOODJITENDRA  PATELVP, Industrial Division ORANGEBURGJITENDRA  PATELVP Sales Industrial Segment Kenneth H  PaulusDirector MINNETONKACheryl  PegusDirector ORANGEBURGLEWIS C  PELLDirector NATICKLEWIS C  PELLVice-Chairman of BOD ORANGEBURGLEWIS C  PELLDirector ORANGEBURGLEWIS C  PELLDirector NATICKBruce  PolskyORANGEBURGBruce  PolskyDirector ORANGEBURGBrett  ReynoldsSVP, CFO, Treasurer ST. PAULKEVIN H  ROCHEDirector MINNETONKAJOHN J  RYDZEWSKIORANGEBURGJOHN J  RYDZEWSKIDirector COSTA MESAJOHN J  RYDZEWSKIDirector ORANGEBURGKENNETH A  SAMETDirector ROCKVILLENACHUM  SHAMIRDirector AUSTINGARY  SIEGELVP, Finance ORANGEBURGKenneth A  SpectorVP R&D FRAMINGHAMJames P  StaunerDirector LAKE FORESTJAMES A  TRACYCFO NEWTONUROPLASTY INCMINNETONKAJOHN J  WALLACEDirector WALTHAMJOHN J  WALLACEDirector WALTHAMJOHN J  WALLACEDirector CANTONJOHN J  WALLACEDirector ORANGEBURGJOHN J  WALLACEBielke  WarrenOrangeburgSVEN  WEHRWEINDirector MINNEAPOLISKatherine  WolfORANGEBURGKatherine  WolfExec. VP, Corp. Dev. & CFO ORANGEBURGKatherine  WolfExec. VP, Corp. Dev. & CFO ORANGEBURGHoward I.  ZaubermanDirector ORANGEBURGPersons related to SVEN  WEHRWEIN - SPS COMMERCE INCNamePositionCityADAMS STREET PARTNERS LLCCHICAGOADAMS STREET PARTNERS LLC10% Owner CHICAGOBlack  ArchieMinneapolisArchie C.  BlackCEO MINNEAPOLISBVCF IV LPCHICAGOBVCF IV LPCHICAGOCID MEZZANINE CAPITAL L PINDIANAPOLISCID Mezzanine Partners, L.P.10% Owner INDIANAPOLISBradley A.  ClevelandDirector MAPLE PLAINSteve A.  CobbDirector INDIANAPOLISNovak, Jr.  DavidMinneapolisDaniel R  FishbackDirector SAN MATEOJames J.  FromeEVP & Chief Operating Officer MINNEAPOLISSpencer,  George IIIMinneapolisMichael B  GormanDirector EDEN PRAIRIEMichael B  GormanDirector MINNEAPOLISMichael J.  GrayEVP of Operations MINNEAPOLISRamsey  JamesMinneapolisFrome  JamesMinneapolisNelson  KimberlyMinneapolisMARTIN J  LEESTMADirector EDEN PRAIRIEMARTIN J  LEESTMADirector MINNEAPOLISLeestma  MartinMinneapolisSmerklo  MichaelMinneapolisGorman  MichaelMinneapolisGray  MichaelMinneapolisKimberly K.  NelsonEVP & CFO MINNEAPOLISDavid J. Jr.  NovakEVP of Business Develpmt MINNEAPOLISSoran  PhilipMinneapolisJames Burr  RamseyDirector SAN MATEOJames Burr  RamseyDirector MINNEAPOLISRCCF Management, Inc.10% Owner CINCINNATITami  RellerDirector REDMONDRiver Citites SBIC III, L.P.CINCINNATIMichael A  SmerkloDirector SAN FRANCISCOMichael A  SmerkloDirector MINNEAPOLISPHILIP  SORANDirector EDEN PRAIRIEPHILIP  SORANDirector EDEN PRAIRIEPHILIP  SORANDirector EDINAGeorge H.  Spencer IIIDirector CHICAGOSplit Rock Partners LLC10% Owner EDEN PRAIRIESPVC AFFILIATES FUND I, LLCEDEN PRAIRIESPVC IV, LLCEDEN PRAIRIESPVC V, LLCEDEN PRAIRIESPVC VI, LLCEDEN PRAIRIEWehrwein  SvenMinneapolisSVEN  WEHRWEINDirector MINNEAPOLISSVEN  WEHRWEINDirector MINNEAPOLISMurray R.  WilsonDirector CINCINNATIPersons related to SVEN  WEHRWEIN - AtriCure, Inc.NamePositionCityElsa Chi  AbruzzoVP Regulatory&Clinical Affairs WEST CHESTERRICHARD M  BERKELEYBALTIMOREStephen S  CambridgeVice President; Sales WEST CHESTERCAMDEN PARTNERS STRATEGIC FUND II A LPBALTIMORECAMDEN PARTNERS STRATEGIC FUND II B LPBALTIMORECAMDEN PARTNERS STRATEGIC II LLCBALTIMOREMICHAEL H  CARRELPresident, CEO, & Director MINNEAPOLISMICHAEL H  CARRELPresident, CEO, & Director WEST CHESTERMark A  CollarDirector WEST CHESTERMark A  CollarDirector CINCINNATIMark A  CollarDirector CINCINNATIMark A  CollarDirector CINCINNATIMark A  CollarDirector CINCINNATIMark A  CollarDirector CINCINNATITimothy J  ConnorsMENLO PARKDiscovery Group I, LLC10% Owner CHICAGODavid J  DrachmanPresident and CEO WEST CHESTERDavid J  DrachmanPresident and CEO WEST CHESTERScott William  DrakeDirector COLORADO SPRINGSScott William  DrakeDirector NIWOTThomas J  EterginoVice President and CFO WEST CHESTERIRWIN  FEDERMANMENLO PARKWINSTON S  FUMENLO PARKREGINA E  GROVESDirector SAN DIEGODONALD C  HARRISONDirector PALO ALTODONALD C  HARRISONDirector INDIAN HILLDONALD C  HARRISONDirector WEST CHESTERDONALD C  HARRISONDirector WEST CHESTERDONALD C  HARRISONDirector CINCINNATIDONALD C  HARRISONDirector INDIAN HILLMichael D  HoovenDirector WEST CHESTERMichael D  HoovenDirector CINCINNATIMichael D  HoovenDirector WEST CHESTERMichael D  HoovenDirector CINCINNATIDONALD W  HUGHESBALTIMOREB KRISTINE  JOHNSONDirector MINNEAPOLISRICHARD M  JOHNSTONDirector RICHARD M  JOHNSTONDirector BATIMORERICHARD M  JOHNSTONDirector BATIMORERICHARD M  JOHNSTONDirector BATIMORERICHARD M  JOHNSTONDirector BALTIMORERICHARD M  JOHNSTONDirector BALTIMORERICHARD M  JOHNSTONDirector BALTIMORERICHARD M  JOHNSTONDirector BALTIMORERICHARD M  JOHNSTONDirector BALTIMOREALAN L  KAGANOVDirector MENLO PARKPatricia J  KennedyVP and GM, International WEST CHESTERSTEVEN M  KRAUSZMENLO PARKElizabeth D  KrellDirector HAGERSTOWNElizabeth D  KrellDirector HAGERSTOWNMark R  LanningDirector OLDENBURGMark R  LanningDirector OLDENBURGMark R  LanningDirector WEST CHESTERMark R  LanningDirector OLDENBERGMark R  LanningDirector OLDENBERGDAVID E  LIDDLEMENLO PARKJames L  LuckyVP, Regulatory Affairs and QA WEST CHESTERJames L  LuckyVP, Clinical, Regulatory & QS WEST CHESTERANDREW L  LUXSVP, Ops & Quality HUDSONANDREW L  LUXSVP, Ops & Quality WEST CHESTERGENE R  MCGREVINALPHARETTADeborah L  MorleyVP Clinical Affairs WEST CHESTERMichael R  MurphyCHICAGOJustin J  NozneskySVP, Mktg & Business Develop MASONSTUART G  PHILLIPSMENLO PARKJulie A  PitonVP Fin & Admin & CFO WEST CHESTERJulie A  PitonVP Fin & Admin & CFO WEST CHESTERFrederick  PreissVice President Operations WEST CHESTERFrederick  PreissVice President Operations WEST CHESTERMANAGEMENT GROUP VIII L L C  PRESIDIO10% Owner MENLO PARKSalvatore  PriviteraVP Engineering & Product Dev WEST CHESTERSalvatore  PriviteraVP Engineering & Product Dev WEST CHESTERKAREN P  ROBARDSDirector PLAINSBOROKAREN P  ROBARDSDirector NEW YORKJONATHAN D  ROOTMENLO PARKChristopher J  RustMENLO PARKDouglas J  SeithChief Operating Officer WEST CHESTERMaureen  ShafferVice President Marketing WEST CHESTERJon A  ShermanVP, Product Development WEST CHESTERStewart W  StrongVice President US Sales WEST CHESTERStewart W  StrongVP Global Marketing WEST CHESTERCasey M  TanseyMENLO PARKUS VENTURE PARTNERS VIII L PMENLO PARKUSVP ENTREPRENEUR PARTNERS VIII A L PMENLO PARKUSVP ENTREPRENEUR PARTNERS VIII B L PMENLO PARKUSVP VIII AFFILIATES FUND L PMENLO PARKM. Andrew  WadeSVP and CFO WEST CHESTERRichard S  WalshVice President; Sales WEST CHESTERDAVID L  WARNOCKBALTIMORESVEN  WEHRWEINDirector MINNEAPOLISNORMAN R  WELDONDirector AMELIA ISLANDROBERT S.  WHITEDirector PLYMOUTHLee R  WrubelDirector ROWAYTONLee R  WrubelDirector WEST CHESTERPHILIP M  YOUNGMENLO PARKPersons related to SVEN  WEHRWEIN - Proto Labs IncNamePositionCityEDWARD T  ANDERSONWALTHAMArthur R.  Baker IIIChief Technology Officer EDEN PRAIRIEArchie C.  BlackDirector MINNEAPOLISMatthew C  BlodgettDirector WALTHAMRobert  BodorVP/General Manager-Americas MAPLE PLAINEdward E.  BoltonVice President, Culture MAPLE PLAINSujeet  ChandDirector MILWAUKEEBradley A.  ClevelandCEO MAPLE PLAINRICHARD A  DAMOREWALTHAMRICHARD A  DAMOREWALTHAMWilliam M.  DietrickVice President of Marketing MAPLE PLAINDAVID M  FEINChief Revenue Officer SUNNYVALERainer  GawlickDirector MAPLE PLAINRanier  GawlickDirector MAPLE PLAINJohn B  GoodmanDirector CHASKAJohn B  GoodmanDirector MAPLE PLAINVICTORIA M  HOLTPresident and CEO PITTSBURGH,VICTORIA M  HOLTPresident and CEO MAPLE PLAINVICTORIA M  HOLTMAPLE PLAINJOHN R  JUDDCFO & Principal Accounting Off MAPLE PLAINDOUGLAS A  KINGSLEYDirector WALTHAMDOUGLAS A  KINGSLEYWALTHAMDOUGLAS W  KOHRSDirector MINNETONKADOUGLAS W  KOHRSDirector MAPLE PLAINDONALD G  KRANTZDirector MAPLE PLAINMark R.  KubicekExecutive Vice President MAPLE PLAINWilliam R.  LangtonEVP of Finance MAPLE PLAINMARGARET A  LOFTUSDirector MAPLE PLAINLAWRENCE J  LUKISDirector MAPLE PLAINNBGE GP, LLCWALTHAMNBGE Manager, LLC10% Owner WALTHAMNORTH BRIDGE GROWTH EQUITY I LPWALTHAMNorth Bridge Growth Management, L.P.WALTHAMThomas H  PangManaging Dir.-Proto Labs G.K. MAPLE PLAINProtomold Investment Company, LLC10% Owner EAGANJacqueline D.  SchneiderVice President Global Sales MAPLE PLAINBrian K  SmithDirector SUITE 150, EAGANBrian K  SmithDirector MAPLE PLAINJohn B.  TumeltyVP/GM & Managing Director-EMEA MAPLE PLAINJOHN  WAYChief Financial Officer MAPLE PLAINSVEN  WEHRWEINDirector MINNEAPOLISSVEN  WEHRWEINDirector MAPLE PLAIN
Potentially same personNameCityCountryWehrwein  SvenEden PrairieMNWehrwein  SvenMinneapolisMN












 

















 












































Sven A. Wehrwein: Executive Profile & Biography - Bloomberg









































  





















































































July 21, 2017 2:01 PM ET
Machinery

Company Overview of Proto Labs, Inc.



SnapshotPeople 




OverviewBoard MembersCommittees



Executive Profile
Sven A. Wehrwein  Chairman and Lead Independent Director, Proto Labs, Inc.AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 12 different industries.See Board Relationships66$181,113
Background

		Mr. Sven A. Wehrwein has been an Independent Financial Consultant to emerging companies since March 1999. He has over 35 years experience in corporate finance and investment banking. He has a 14-year career in investment banking for Dean Witter Reynolds. He served as the Chief Financial Officer of Digi International Inc. from December 1998 to February 1999 and Center for Diagnostic Imaging from November 1997 to July 1998. Mr. Wehrwein served as Operating Partner of Blackford ... Capital LLC. He served as the Chief Financial Officer of Medtronic Instent, Inc. from June 1995 to August 1996 and served as its Principal Accounting Officer. He served as Managing Director in the Corporate Finance Department of Wessels, Arnold & Henderson from July 1990 to December 1994. Since 1999, he has provided financial-consulting services to emerging growth companies. He served as Managing Director of Drexel Burnham Lambert. He began his career as a Certified Public Accountant on the Audit Staff of Coopers & Lybrand. He has been the Chairman of Proto Labs, Inc. since May 19, 2017 and serves as its Lead Independent Director. He has been a Director of Uroplasty Inc., since August 2006, an Independent Director of SPS Commerce, Inc. since July 2008, Celleration, Inc. since October 4, 2008 and Quantum Retail Technology, Inc. since June 2, 2014. He has been a Director of Proto Labs, Inc. since June 2011. He has been Director at AtriCure, Inc. since November 11, 2016. He serves as an Independent Director of various funds in the fund complex of Van Wagoner Funds/Embarcadero Funds. He served as an Independent Director of Synovis Life Technologies Inc. from December 1, 2004 to February 14, 2012. He served as an Independent Director of Cogentix Medical, Inc. since August 2014 until March 2016. He served as an Independent Director of Vital Images, Inc. from May 1997 to June 2011. He served as Director of ZAMBA LLC since June 1999. He served as a Director at Image Sensing Systems Inc. since October 2006. He served as an Outside Director of Compellent Technologies, Inc. from April 2007 to February 22, 2011. He is an award-winning Freelance Financial Journalist and regularly contributes to Twin Cities Business Monthly. He is a Certified Public Accountant from AICPA. He holds a Master of Business Administration in Finance from the Sloan School of Management at the Massachusetts Institute of Technology and a Bachelors of Science degree in Business from Loyola University in Chicago, Illinois.Read Full Background




Corporate Headquarters
5540 Pioneer Creek DriveMaple Plain, Minnesota 55359United StatesPhone: 763-479-3680Fax: 763-479-2679
Board Members Memberships
Independent DirectorVan Wagoner Small-Cap Growth Fund2008-PresentIndependent DirectorSPS Commerce, Inc.2008-PresentDirectorCelleration Inc.2011-PresentChairman and Lead Independent DirectorProto Labs, Inc.2014-PresentDirectorQuantum Retail Technology, Inc.2016-PresentDirectorAtriCure, Inc.
Education
BS Loyola University ChicagoMBA MIT Sloan School of Management
Other Affiliations
SPS Commerce, Inc.ZAMBA LLCSynovis Life Technologies Inc.Medtronic Instent, Inc.Image Sensing Systems, Inc.Vital Images, Inc.AtriCure, Inc.Blackford Capital LLCCogentix Medical, Inc.Loyola University ChicagoCelleration Inc.Compellent Technologies, Inc.MIT Sloan School of ManagementVan Wagoner Small-Cap Growth FundEmbarcadero Funds - Absolute Return FundVan Wagoner Funds Inc.- Van Wagoner Growth Opportunities FundEmbarcadero Fund - Market Neutral FundQuantum Retail Technology, Inc.


Annual Compensation
				There is no Annual Compensation data available.
				Stocks Options
				There is no Stock Options data available.
				Total Compensation
Total Annual Cash Compensation$81,113Total Calculated Compensation$181,113




Request Profile Update
















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



COMPETITOR COMPENSATIONNamePosition/CompanyCompensationIlan  Levin CEO & DirectorStratasys Ltd.--Vyomesh I. Joshi Chief Executive Officer, President and Director3D Systems Corporation$661.7KYasuo  Suzuki President & Representative DirectorARRK Corporation--Wilfried  Vancraen Founder, Chief Executive Officer and Director Materialise NV--Compensation as of Fiscal Year --.










Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Proto Labs, Inc., please visit .  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close





























403 - Forbidden: Access is denied.



Server Error


403 - Forbidden: Access is denied.
You do not have permission to view this directory or page using the credentials that you supplied.







SPSC Sven A. Wehrwein Insider Trades for SPS Commerce Inc.


































Bulletin






Investor Alert







New York Markets Close in:



Market Snapshot
Winners and Losers


















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































SPS Commerce Inc.

                  NASDAQ: SPSC
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

SPS Commerce Inc.



Market open
 --Real time quotes
Jul 21, 2017, 1:58 p.m.


SPSC

/quotes/zigman/117638/composite


$
59.35




Change

-0.54
-0.90%

Volume
Volume 83,225
Real time quotes








/quotes/zigman/117638/composite
Previous close

$
			59.89
		


$
				59.35
			
Change

-0.54
-0.90%





Day low
Day high
$59.33
$62.08










52 week low
52 week high

            $48.11
        

            $74.85
        


















Insider Activity


Individual




Sven A. Wehrwein



Mr. Sven A. Wehrwein, CPA, is Independent Director at Cogentix Medical, Inc., Lead Independent Director at Proto Labs, Inc., and Independent Director at SPS Commerce, Inc. He is on the Board of Directors at Cogentix Medical, Inc., Proto Labs, Inc., SPS Commerce, Inc., and Staging Concepts, Inc.
Mr. Wehrwein was previously employed as Independent Director by Image Sensing Systems, Inc., Independent Director by Uroplasty LLC, Independent Director by Synovis Life Technologies, Inc., Chief Financial Officer by Digi International, Inc., Chief Financial Officer by InStent, Inc., Investment Banker by Dean Witter Reynolds, Inc., Investment Banker by Drexel Burnham Lambert Real Estate Associates II, a Managing Director by Wessels Arnold & Henderson LLP, Operating Partner by Blackford Capital LLC, and a Principal by Coopers & Lybrand LLP. He also served on the board at Quantum Retail Technology, Inc., Compellent Technologies, Inc., Van Wagoner Cos., Inc., Zamba Corp., and Vital Images, Inc.
He received his undergraduate degree from the Loyola University of Chicago and a graduate degree from the Massachusetts Institute of Technology.



Transactions


Date
Shares
Transaction
Value





05/23/2017
909


 
Award at $0 per share.


0


05/18/2016
1,013


 
Award at $0 per share.


0


05/14/2015
685


 
Award at $0 per share.


0


02/26/2015
2,000


 
Disposition at $70 per share.


140,000


02/26/2015
2,000


 
Derivative/Non-derivative trans. at $3.03 per share.


6,060


02/25/2015
2,000


 
Disposition at $68 per share.


136,000


02/25/2015
2,000


 
Derivative/Non-derivative trans. at $3.03 per share.


6,060


06/06/2014
1,000


 
Disposition at $59.62 per share.


59,620


06/06/2014
1,000


 
Derivative/Non-derivative trans. at $3.03 per share.


3,030


05/15/2014
892


 
Award at $0 per share.


0


08/05/2013
4,000


 
Disposition at $70 per share.


280,000


08/05/2013
4,000


 
Derivative/Non-derivative trans. at $3.03 per share.


12,120


05/22/2013
2,000


 
Disposition at $51.12 per share.


102,240


05/22/2013
2,000


 
Derivative/Non-derivative trans. at $3.03 per share.


6,060


05/17/2013
1,000


 
Disposition at $49.57 per share.


49,570


05/17/2013
1,000


 
Derivative/Non-derivative trans. at $3.03 per share.


3,030


05/16/2013
1,000


 
Disposition at $49.2 per share.


49,200


05/16/2013
1,000


 
Derivative/Non-derivative trans. at $3.03 per share.


3,030


05/15/2013
948


 
Award at $0 per share.


0


05/06/2013
1,496


 
Disposition at $47 per share.


70,312


05/06/2013
1,496


 
Derivative/Non-derivative trans. at $3.03 per share.


4,532


05/03/2013
504


 
Disposition at $47 per share.


23,688


05/03/2013
504


 
Derivative/Non-derivative trans. at $3.03 per share.


1,527


03/14/2013
1,000


 
Disposition at $38.12 per share.


38,120


03/14/2013
1,000


 
Derivative/Non-derivative trans. at $3.03 per share.


3,030


03/06/2013
1,000


 
Disposition at $37.9 per share.


37,900


03/06/2013
1,000


 
Derivative/Non-derivative trans. at $3.03 per share.


3,030


12/10/2012
2,000


 
Disposition at $36.75 per share.


73,500


12/10/2012
2,000


 
Derivative/Non-derivative trans. at $3.03 per share.


6,060





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Mr. Archie C. Black 
President, Chief Executive Officer & Director




Mr. James J. Frome 
Chief Operating Officer & Executive Vice President




Ms. Kimberly K. Nelson 
Chief Financial Officer & Executive Vice President




Mr. Jamie  Thingelstad 
Chief Technology Officer & Senior Vice President




Ms. Beth M. Jacob 
Chief Customer Success Officer & Senior VP




Mr. Martin J. Leestma 
Director




Ms. Tami L. Reller 
Director




Mr. Dan  Juckniess 
Chief Sales Officer & Senior Vice President




Mr. F. Peter Zaballos 
Chief Marketing Officer & Senior Vice President




Mr. Kay  Rindels 
Head-Investor Relations




Mr. Mike  Carey 
Chief Human Resources Officer & Senior VP




Mr. Philip E. Soran 
Independent Director




Mr. Sven A. Wehrwein 
Independent Director




Mr. James Burr Ramsey 
Independent Director




Mr. Michael A. Smerklo 
Independent Director









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




2:01 PM EDT
July 21, 2017


/marketstate/country/us
New York

	Open


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
2:01pThis week’s retirement news
2:01pHollywood is using social causes to sell movie tickets 
2:00pWhite House briefs reporters after Spicer quits as press secretary: live blog
1:49pGold marks highest settlement in a month, up over 2% for the week
1:48pSpicer says in a tweet he'll continue in job through August
1:43pAugust gold climbs $9.40, or 0.8%, to settle at $1,254.90/oz
1:43pGold prices end at highest level in a month, up over 2% for the week
1:36pEuropean stocks log worst daily drop in 3 weeks as euro rallies
1:35pOil drops to a 1-week low with OPEC output expected to rise
1:32pHome-security company ADT could go public by the end of the year
1:26pGE’s stock falls as Jeff Immelt’s 64th and last quarter is another disappointment
1:21pEuro rally has room to run if this pattern continues to hold true
1:16pSean Spicer just quit. Should you be next?
1:15pPetIQ shares soaring 32% in company's market debut 
1:11pAmazon’s foray into groceries means more mergers of food companies, experts say
1:11pFTSE 100 ends lower, but retains grip on weekly gain  
1:08pBaker Hughes data show U.S. oil-rig count down for first time in three weeks
1:07pStock market retreats as GE casts pall on earnings season 
1:07pPetIQ shares up 32% in company's market debut 
1:06pHoneywell upgraded to buy from hold at CFRA
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,572.57

-39.21
-0.18%





nasdaq

/quotes/zigman/12633936/realtime
6,381.86

-8.14
-0.13%





s&p 500

/quotes/zigman/3870025/realtime
2,470.84

-2.61
-0.11%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15

































































Board of Directors



















































Skip to main content







Search form

Search 


United States / International



 

















Michael Carrel / Mark Collar / Scott Drake / Regina Groves / Kristine Johnson / Richard Johnston / Elizabeth Krell / Mark Lanning / Sven Wehrwein / Bob White
 
Michael H. Carrel
Mr. Carrel has served as President, Chief Executive Officer and director since November 2012. Mr. Carrel served as President and Chief Executive Officer of Vital Images, a publicly-traded medical imaging software company from 2008 until 2012 until it was sold to Toshiba. Mr. Carrel originally joined Vital Images in January 2005 as Chief Operating Officer and Chief Financial Officer. Prior to Vital Images, Mr. Carrel was President and CEO of Zamba Corporation, a publicly-traded technology company and Chief Financial Officer of NextNet Wireless, a privately-held provider of non-line-of-sight plug and play broadband wireless access systems, now part of Motorola. Mr. Carrel is a member of the Board of Directors of Lombard Medical, Inc. and the American Heart Associations of Cincinnati and Minnesota. Mr. Carrel holds a B.S. in Accounting from The Pennsylvania State University and an M.B.A. from The Wharton School at the University of Pennsylvania. Back to top
 
Mark A. Collar
Mr. Collar has served as one of our directors since February 2008. Mr. Collar retired in 2008 as an officer within the Procter and Gamble Company where his roles included President of the Global Pharmaceuticals and Personal Health business. Mr. Collar joined Procter and Gamble in 1975 as a sales representative, then moved into advertising, and subsequently assumed roles of progressive responsibility within the Health and Personal Care, Beauty Care, New Business Development, Pharmaceuticals and Personal Health Care Products divisions over his 32-year career. Mr. Collar, who now owns his own investment and consulting business, is a director of First Financial Bancorp, a publicly-held bank holding company and Enable Injections, a start-up company focusing on high volume injection devices for biologic drugs, and serves in director and advisory roles in several philanthropic, academic and economic development organizations. Mr. Collar received his B.S. from Northern Illinois University. Mr. Collar’s experience as a public company executive and board member provides him insight into high-level corporate governance and business management matters which the Board considers on a regular basis. Back to top
 
Scott Drake
Mr. Drake has served as one of our directors since September 2013. Mr. Drake currently serves as President and Chief Executive Officer of the Spectranetics Corporation. Spectranetics is a publicly-held growth company that develops, manufactures and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. The company’s products are sold in more than 40 countries and are used to access and treat arterial blockages in the legs and heart and to remove pacemaker and defibrillator cardiac leads. The 2014 acquisition of AngioScore, Inc. broadened the company’s portfolio of highly differentiated technologies and supports the organization’s aggressive growth trajectory. Prior to joining Spectranetics, Mr. Drake served as Senior Vice President, Operations of DaVita, Inc., a leading U.S. provider of kidney care and dialysis, from 2009 to August 2011. Previously, Mr. Drake held several positions of increasing responsibility within various healthcare business units at Covidien, Plc over a period of 17 years, including: Global Business Unit President, Respiratory and Monitoring Solutions, President, Valleylab (re-named as the Surgical Solutions Group) and Vice President and General Manager, Critical Care. Mr. Drake is an EY 2014 Entrepreneur Of The Year™. He serves on the Board of Directors for the Spectranetics Corporation, Just Right Surgical, and the Medical Device Manufacturers Association (MDMA). Mr. Drake holds a B.S. in Business Administration from Miami University of Ohio. As a seasoned executive, Mr. Drake has significant leadership experience managing growing businesses, achieving sustainable revenue growth and driving operational improvements which the Board considers as valuable skills for evaluating and improving the Company’s competitive position. Back to top
 
Regina Groves
Ms. Groves has served as one of our directors since March 2017. Ms. Groves has been the Chief Executive Officer at REVA Medical, Inc. (ASX: RVA), since September of 2015. Prior to her current position, Ms. Groves served as Vice President and General Manager of the AF Solutions, Cardiac Rhythm and Heart Failure Division of Medtronic, a leading global medical technology company. In this position, she successfully developed and executed strategies to re-enter the catheter-based Afib ablation market and achieved the goal to be market leader in paroxysmal, or intermittent, Afib ablation. The role also allowed her to successfully acquire and integrate companies, complete numerous clinical trials, and launch novel products in the United States and worldwide. Prior to this, she was the Vice President of Quality and Regulatory for Medtronic’s Cardiac Rhythm Disease Management (“CRDM”) business from 2006 to 2008 and before that was Vice President and General Manager for Patient Management CRDM at Medtronic from 2002 to 2006. Back to top
 
B. Kristine Johnson
Ms. Johnson has served as one of our directors since March 2017. Ms. Johnson is currently president of Affinity Capital Management, a venture capital firm that invests primarily in seed and early-stage health care companies in the United States, a position she has held since 2000. In addition to her role at Affinity, Ms. Johnson currently serves on the boards of directors of Piper Jaffray (NYSE: PJC), The Spectranetics Corporation (NASDAQ: SPNC), and the University of Minnesota Foundation Investment Advisors, as well as the boards of several private entities. Prior to her role at Affinity, Johnson was employed for 17 years at Medtronic, serving most recently as senior vice president and chief administrative officer from 1998 to 1999. Her experience at Medtronic also includes service as president of the vascular business and president of the tachyarrhythmia management business, among other roles. Back to top
 
Richard Johnston
Mr. Johnston has served as one of our directors since June 2002 and as Chairman of the Board since February 2005. From 2000 to 2010, Mr. Johnston served as a Managing Member of Camden Partners Holdings, LLC, a private equity firm, and he is now a Retired Member of that firm and provides certain consulting services to it. Mr. Johnston currently serves as a director of BioMedical Enterprises, Inc. Mr. Johnston has previously served as director of privately-held LipoScience Inc., Lombard Medical Technologies PLC, a publicly-held company in the United Kingdom, Medivance, Inc. and Webmedx, Inc., all Camden Partners portfolio companies. He also served as Chairman of privately-held Picis, Inc. as well as a director of Pet DRx Corporation, a publicly-held company. From 1961 to 2000, Mr. Johnston was employed by The Hillman Company, an investment holding company with diversified operations, where he served from 1970 to 2000 as Vice President, Investments and as a director. From 1979 to 2003, Mr. Johnston was Chairman of the Board of The Western Pennsylvania Hospital and its successors, The Western Pennsylvania Healthcare System and West Penn Allegheny Health System. Mr. Johnston received his B.S. from Washington and Lee University and his M.B.A. from The Wharton School at the University of Pennsylvania. Mr. Johnston’s service as a director of several medical device companies and chairman of the board of a large healthcare system provides him insight into the high-level corporate governance, executive compensation and business management matters that the Company and the Board consider on a regular basis. Back to top
 
Elizabeth D. Krell, Ph.D.
Dr. Krell has served as one of our directors since June 2006. Dr. Krell is currently a private consultant on matters pertaining to Food and Drug Administration (FDA) regulated products, as well as FDA policies and procedures. From 2003 to 2004, she served as the Executive Vice President for Technology and Regulatory Affairs at the Advanced Medical Technology Association (AdvaMed), the largest trade association for medical device manufacturers. From 1975 to 2001, she served in the FDA, starting as a bench researcher and ending in the FDA’s top science job as the Acting Senior Advisor for Science, advising the Commissioner and other top FDA officials on science and science management. Dr. Krell served from 1990 to 2001 as the Deputy Director for Science in the FDA’s Center for Devices and Radiological Health (CDRH). In this position, she provided executive leadership in the development of programs to assure the safety and effectiveness of medical devices and diagnostic products and the reduction of population exposure to radiation emitted from medical, industrial and consumer products. Previously, she directed CDRH’s science and engineering labs. Dr. Krell currently serves as a member of the Board of Trustees of the Global Medical Device Nomenclature Agency. Dr. Krell received her B.A. from S.U.N.Y. Binghamton and her Ph.D. from Georgetown University. Dr. Krell brings valuable risk assessment and healthcare compliance skills to the Board as a result of her experience designing safety and effectiveness programs as well as familiarity with many aspects of the FDA’s policies and procedures, which plays an important part in the Company’s business. Back to top
 
Mark R. Lanning, CPA, CGMA
Mr. Lanning has served as one of our directors since February 2006. Mr. Lanning currently is a financial consultant and a principal with the Lanning CPA group. Most recently Mr. Lanning served as Vice President-Finance and Chief Financial Officer of Frisch’s Restaurants for over 5 years. Prior to joining Frisch’s, Mr. Lanning served as Vice President, Investor Relations and Treasurer of Hillenbrand, Inc., Hill-Rom, Inc. and Hillenbrand Industries, diversified leaders in the healthcare equipment, funeral services, and material handling industries. Prior to joining Hillenbrand in 1988, Mr. Lanning spent twelve years in various accounting positions with Ernst & Whinney (now EY). Mr. Lanning, a Certified Public Accountant and a Chartered Global Management Accountant, is presently a member of the American Institute of CPAs (AICPA). In addition, he has served as a member of Council of the AICPA and is a past Chairman and Board member of the Indiana CPA Society. Mr. Lanning received his B.S. in Accounting from Ball State University. As a certified public accountant, Mr. Lanning developed significant experience in preparing, auditing, analyzing and evaluating financial statements and dealt with broad and complex accounting issues comparable to those of the Company, which qualifies him as an “audit committee financial expert” under SEC rules. Back to top
 
Sven A. Wehrwein
Sven A. Wehrwein has served on our board of directors since November 2016. Mr. Wehrwein has been an independent financial consultant to emerging companies since 1999. He has more than 35 years of experience as an investment banker, chief financial officer, and certified public accountant. Wehrwein currently serves on the boards of several companies, including Proto Labs, Inc. and SPS Commerce, Inc. In addition, he has served as a Director for a number of other medical device and high growth companies including tenures on the boards of Compellent Technologies, Synovis Life Technologies, and Vital Images. Back to top
 
Bob White
Mr. White has served as one of our directors since March 2013. Mr. White serves as President and Chief Operating Officer of Entellus Medical, a privately-held company that delivers innovative, high quality, minimally invasive therapeutic solutions to healthcare providers and their patients who suffer from sinusitis. Prior to joining Entellus, Mr. White served as President and CEO of TYRX, a privately-held company acquired by Medtronic, Inc. TYRX commercializes innovative, implantable combination drug and device products focused on infection control. Prior to joining TYRX, Mr. White held several positions with Medtronic, Inc. Mr. White served as President of Medtronic Kyphon following its $3.9 billion acquisition of the spinal treatment business. During his time with Medtronic, Mr. White also served as President of Physio Control and was responsible for commercial operations of the Cardiac Rhythm Disease Management business as Vice President of U.S. Sales and Global Marketing. Earlier in his career, Mr. White held positions with General Electric Company and Eli Lilly and Company, among others. Mr. White serves on the Board of Directors of Novadaq, a publically traded provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, and HyperBranch Medical Technology, a privately-held company that develops and markets products capable of adhering tissues, promoting healing, preventing fluid and air leaks, and reducing infections. Mr. White holds a B.S. in Aerospace Engineering from the University of Missouri-Rolla and an M.B.A. from Cornell University. The Board believes that Mr. White’s significant knowledge of the medical device industry and experience in growing companies commercially uniquely benefit AtriCure and enhance its capacities in business development initiatives. Back to top
 



 


















RF Ablation, Pacing and Sensing
Bipolar RF Clamps
Versapolar RF with Suction
Minimally Invasive
Linear Pens and Probes
Capital Equipment

Soft Tissue Dissection
Devices

 









Cryo
Cryoablation Probes
Cryoanalgesia Probe
Capital Equipment

Left Atrial Appendage Management
AtriClip Devices
AtriClip PRO Devices
Accessories

 











Cart Configurations
Basic Cart
Simple Cart
Fusion Cart

Estech Valve Instrumentation
Access
LiV Instruments

 









Instructions for Use (IFUs)
USA
 
 
 
 












